Stay updated on Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Sign up to get notified when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page adds an expanded Locations section with 19 state site entries (Alabama, Arizona, Arkansas, California, Florida, Idaho, Illinois, Indiana, Kentucky, Michigan, Missouri, Nebraska, New Jersey, New York, North Carolina, Oklahoma, Rhode Island, South Carolina, Texas) and updates the revision to v3.3.3; the HHS Vulnerability Disclosure section was removed.
    Difference
    2%
    Check dated 2025-12-22T01:38:11.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    This change is a minor revision update from v3.3.1 to v3.3.2 and does not modify the study data or parameters. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T16:30:29.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page adds a note that PubMed publications are auto-filled for the study and updates the page revision from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-23T14:49:41.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The site-wide banner about government funding and NIH operating status on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-16T14:16:19.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The updates appear to be minor formatting and text edits on the Study Details page, with no changes to the primary outcomes, study design, enrollment, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-02T00:37:56.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a new operating-status notice about government funding and a link to operating status details; removes v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-04T11:11:10.000Z thumbnail image

Stay in the know with updates to Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.